Trials / Completed
CompletedNCT03373630
Prospective Analysis of Incidence and Risk Factors of Infection of Midline Catheter
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Groupe Hospitalier Mutualiste de Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Midline catheter is a peripherally-inserted catheter, with the distal tip being placed at or below the level of the axilla. It is a relevant alternative to other catheters in case of limited venous access and long-run perfusions. Moreover, another significant advantage may be the reduction of the risk of infection. However, the Midline catheter is poorly described in scientific literature, essentially through retrospective and meta analyses including multiple types of catheters (Piccline, CVC, PAC). Therefore, the TIM-GHM study aims to prospectively assess the rate of infections in case of the Midline catheter. The results of this study could bring a collective benefit in terms of knowledge and reliability of these intravascular devices. Depending on these results, a randomized, controlled study will be considered, in order to compare the Midline catheter to its main alternative : the Piccline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Midline catheter | The catheter will be inserted according to usual practices, after the enrollment of the patient in the study. The follow-up will last until the removal of the catheter, which will also be done according to usual practices. Following the removal, bacteriologic analyses will be performed in order to diagnose any prospective infection. |
Timeline
- Start date
- 2018-01-16
- Primary completion
- 2019-10-21
- Completion
- 2019-10-21
- First posted
- 2017-12-14
- Last updated
- 2019-12-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03373630. Inclusion in this directory is not an endorsement.